Clinical Trial Update: A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma

View source ↗

Summary

This clinical trial is investigating molecular-subtyping-based therapeutic strategies for Cutaneous T-cell Lymphoma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides

Snippet

Sponsor: Peking University First Hospital | Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T Cell Lymphoma | Status: RECRUITING